Immunogenicity and safety of a measles-mulps-rubella-varicella vaccine following a 4-week or a 12-month interval between two doses

H C Rümke, K Hoppenbrouwers, C. Vandermeulen, Anne Malfroot, K Helm, M Douha, P. Willems

Onderzoeksoutput: Article › peer review

30 Citaten (Scopus)

Citeer dit

@article{985021ceeec44117a0726eb553039e89,

title = "Immunogenicity and safety of a measles-mulps-rubella-varicella vaccine following a 4-week or a 12-month interval between two doses",

keywords = "vaccine",

author = "R{\"u}mke, {H C} and K Hoppenbrouwers and C. Vandermeulen and Anne Malfroot and K Helm and M Douha and P. Willems",

year = "2011",

language = "English",

volume = "29",

pages = "3842--3849",

journal = "Vaccine",

issn = "0264-410X",

publisher = "Elsevier BV",

number = "may 17",

}

TY - JOUR

T1 - Immunogenicity and safety of a measles-mulps-rubella-varicella vaccine following a 4-week or a 12-month interval between two doses

AU - Rümke, H C

AU - Hoppenbrouwers, K

AU - Vandermeulen, C.

AU - Malfroot, Anne

AU - Helm, K

AU - Douha, M

AU - Willems, P.

PY - 2011

Y1 - 2011

KW - vaccine

M3 - Article

VL - 29

SP - 3842

EP - 3849

JO - Vaccine

JF - Vaccine

SN - 0264-410X

IS - may 17

ER -